0001567619-23-005259.txt : 20230317
0001567619-23-005259.hdr.sgml : 20230317
20230317162902
ACCESSION NUMBER: 0001567619-23-005259
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NICOLS JOHN J
CENTRAL INDEX KEY: 0001238884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34705
FILM NUMBER: 23743011
MAIL ADDRESS:
STREET 1: ALBEMARLE CORP
STREET 2: 451 FLORIDA ST
CITY: BATON ROUGE
STATE: LA
ZIP: 70801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CODEXIS, INC.
CENTRAL INDEX KEY: 0001200375
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 710872999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-421-8100
MAIL ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: CODEXIS INC
DATE OF NAME CHANGE: 20021022
4
1
doc1.xml
FORM 4
X0306
4
2023-03-15
0
0001200375
CODEXIS, INC.
CDXS
0001238884
NICOLS JOHN J
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2023-03-15
4
M
0
35714
1.97
A
819679
D
Common Stock
2023-03-15
4
S
0
35714
4.0917
D
783965
D
Common Stock
2023-03-16
4
M
0
35714
1.97
A
819679
D
Common Stock
2023-03-16
4
S
0
35714
4.1071
D
783965
D
Stock Option (Right to Buy)
1.97
2023-03-15
4
M
0
35714
0
D
2018-02-24
2024-02-23
Common Stock
35714
249998
D
Stock Option (Right to Buy)
1.97
2023-03-16
4
M
0
35714
0
D
2018-02-24
2024-02-24
Common Stock
35714
214284
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.
This transaction was executed in multiple trades in prices ranging from $4.02 to $4.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $4.01 to $4.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Sriram Ryali, as Attorney-in-Fact for John J. Nicols
2023-03-17